Skip to main navigation Skip to search Skip to main content

Ancillary Study to BRT/BP-01 (a clinical trial investigating Bertilimumab in Bullous Pemphigoid)

Project: Research

Project Details

StatusFinished
Effective start/end date08/15/16 → 08/14/19

Funding

  • Immune Pharmaceuticals: $31,400.00